polymorphisms (VDR FokI: rs10735810, CYP27B1: rs10877012; CYP2R1: rs10741657, rs2060793; CYP24A1: rs6013897; GC: rs4588, rs7041, rs2282679, rs1155563; NADSYN1: rs12785878, rs3829251; C10orf88: rs6599638), and were analyzed along with the neighboring single nucleotide polymorphisms (SNPs) (GC: rs705117; NADSYN1: rs10898191). The sequences of PCR primers and the PCR conditions will be provided on request.
Statistical analysis
Values are expressed as mean ± SD. The goodness of fit to the Hardy-Weinberg equilibrium was determined by comparing the calculated expected frequency of each genotype with the observed value using a χ 2 test. Comparisons of genotype frequency and allele frequency between patients and control subjects were performed using a χ 2 test for 2 × 2 or 2 × 3 tables, with Yates' correction if necessary. Genotype and the clinical data were compared using a Student's t-test. Statistical significance was set at p < 0.05.
Results

SNP analysis
The characteristics of the patient group were summarized in Table 1 . Seven patients had no risk factors other than breast-feeding. None of the patients had gated an association between gene polymorphisms and manifestation of vitamin D deficiency.
In this study, we analyzed previously reported vitamin D-related polymorphisms in Japanese children manifesting vitamin D deficiency.
Subjects and Methods
Subjects
Thirty Japanese patients manifesting vitamin D deficiency were included in the study. Selection criteria for patient participation in the study were as follows: vitamin D deficiency presenting at less than 4 years of age, vitamin D deficiency presenting with either overt rickets or hypocalcemic seizures, taking no medication that interferes with vitamin D metabolism, and having no history of rickets of prematurity. Clinical diagnosis of vitamin D deficiency was made by assessing hypocalcemia and/ or hypophosphatemia, high serum alkaline phosphatase (ALP) levels, typical findings of rickets on bone roentgenogram, low circulating 25(OH)D levels, and elevated serum parathyroid hormone (PTH) levels. The control group consisted of 66 healthy Japanese volunteers with no history of rickets or hypocalcemic seizures.
The study protocol was approved by the ethical committees of the University of Tokyo and Yamagata University and was performed according to the Declaration of Helsinki. Written informed consent for DNA analyses was obtained from the parents of patients and healthy individuals.
Gene analysis
We selected polymorphisms that have been reported to be associated with serum 25(OH)D levels in either GWAS or candidate gene studies [8, 9, 11, 12, [15] [16] [17] [18] [19] [20] . Well-known VDR polymorphisms reported to be associated with bone mineral density and several vitamin D-related diseases were also included [21] [22] [23] . Genomic DNA was isolated from peripheral white blood cells, and PCR-restriction fragment length polymorphism was performed for VDR BsmI, ApaI, and TaqI (rs1544410, rs7975232, and rs731236, respectively) as previously reported [24] . VDR polyA polymorphism (rs17878969) was analyzed by GeneScan as previously reported [23] , and based on the number of consecutive adenines (As) within the repeat sequence, polymorphism was classified as "L" (long), with more than 17 As, or "S" (short), with 17 or less As. PCR-direct sequencing was performed for other (7. 82 ng/ml), and three with competitive proteinbinding assay (11.8, 20.7, 22 .9 ng/mL).
D levels in a GWAS [11] . Moreover, the association of rs3829251 with reduced 25(OH)D levels was also found in a Chinese cohort [14] . rs705117 in GC is 268 bp away from rs2282679, which is associated with reduced 25(OH)D levels in both Caucasians and Chinese [11, 12, 14] . We believe that polymorphisms in these genes are also associated with low 25(OH)D levels in the Japanese population.
The influence of environmental factors such as vitamin D intake or ultraviolet radiation levels on other diseases have been reported to differ with VDR genotype [23, 30] . Individuals with VDR minor genotypes are more sensitive to vitamin D administration and exhibit low calcium absorption [31, 32] . Moreover, VDR minor alleles have been reported to alter VDR function or expression [33, 34] . Otherwise, VDRmediated regulation of 24-hydroxylase may be modified by altered VDR function, thereby influencing the degradation of 25(OH)D and 1,25(OH) 2 D. Taken our results together, we believe that children with VDR minor haplotype may be more influenced by vitamin D insufficiency and more likely to manifest overt rickets or hypocalcemia. This genetic predisposition may explain why only some of the thousands of children with low 25(OH)D levels manifest symptoms, while the majority are symptom free.
So far, many reports have shown an association between VDR polymorphisms and bone mineral density or osteoporosis [22, 35] . In particular, BsmI, ApaI, TaqI, and polyA polymorphisms around the last exon are in linkage disequilibrium and have been extensively investigated. The two most relevant findings among several reports and a meta-analysis are that 1) the B allele of BsmI is related to reduced bone mineral density and 2) Bat and BAt haplotypes are significantly associated with osteoporosis [36, 37] . The risk associated with a minor haplotype in reducing positive action of vitamin D is consistent with the results of this study.
Numerous reports indicate an association between VDR polymorphisms and diseases such as cancer and autoimmune diseases [22] . In particular, minor alleles around the last exon of VDR have been reported to be associated with type 1 diabetes, multiple sclerosis, and prostate cancer in Japanese patients [27] [28] [29] 38] . Vitamin D insufficiency is a risk factor for all these diseases [39] . Considering our results together, we believe that individuals with these minor alleles are at increased risk of the diseases because they are more influenced by vitamin D insufficiency. However, a mutation in the CYP2R1 coding region (enzyme for vitamin D 25-hydroxylation) [25] .
The distribution of the analyzed SNPs in the control group was in accordance with the assumption of Hardy-Weinberg equilibrium. We compared genotype and allele frequencies between patients and controls. Genotype frequencies of BsmI polymorphism in VDR and rs10898191 in NADSYN1 were significantly different between the patient and control groups ( Table  2 ). The allele frequencies of the B allele of BsmI, A allele of ApaI, and t allele of TaqI, all minor alleles of VDR, were significantly increased in the patient group (p < 0.05; Table 3 ). For other genes, the minor alleles of rs10898191 in NADSYN1 and rs705117 in GC were significantly increased in the patient group (p < 0.05).
Haplotype analysis
BsmI, ApaI, TaqI, and polyA polymorphisms in VDR lie near or within the last exon and are in linkage disequilibrium [26] . Because all alleles with increased frequency in the patients were minor alleles, we analyzed the frequency of the minor BAtS haplotype between the two groups and discovered a significantly increased frequency in the patient group relative to the control group (p = 0.0014; odds ratio, 5.61; 95% confidence interval 1.92 -16.40; Table 4 ).
Association of genotype and clinical features
We compared age at onset, presence of risk factors other than breast-feeding, serum calcium levels, serum 25(OH)D levels, and serum 1,25-dihydroxyvitamin D [1,25(OH) 2 D] levels between patients with or without the BAtS haplotype or the high-risk alleles of rs10898191 and rs705117. However, we found no significant differences in any of these parameters (data not shown).
Discussion
We observed that polymorphisms in VDR, GC, and NADSYN1 were associated with vitamin D deficiency. Moreover, patients harboring the minor BAtS haplotype had a 5.6-fold increased risk of vitamin D deficiency. The minor allele frequency of each VDR polymorphism in the control group was comparable to that in other Japanese controls, indicating no bias in the selection of the control group [27] [28] [29] . rs10898191 in NADSYN1 is 42 bp away from rs3829251, which has been reported to be associated with reduced 25(OH) ommended for all infants, especially those who are breast-fed [45] . However, some children are genetically sensitive to vitamin D supplementation and may become hypercalcemic after this treatment [46] . Together with our finding of genetic predisposition for vitamin D deficiency, we believe that genetic factors should be taken into account in the future design of personalized supplementation. In addition, large studies on patients with overt symptoms of vitamin D deficiency are necessary. In summary, although only a limited number of subjects were investigated, we found an association of VDR, GC, and NADSYN1 polymorphisms with vitamin D deficiency. Considering that only some children with reduced serum 25(OH)D levels manifest overt symptoms of vitamin D deficiency, our findings suggest that polymorphisms of these genes may be linked to the manifestation of vitamin D deficiency in Japanese children.
larger studies are necessary to confirm the relationship between the risk of vitamin D deficiency in childhood and other diseases related to vitamin D insufficiency.
Some studies investigating the genetic factors involved in vitamin D-deficient rickets identified association with VDR ApaI and FokI polymorphisms, whereas others found no association with BsmI, ApaI, and TaqI polymorphisms [40] [41] [42] [43] . Additionally, an almost significant degree of association has been reported between ApaI polymorphism and osteomalacia [44] . Although these associations are not identical to our data, probably because of differences in ethnicity, we believe that VDR is most likely to be one of the disease susceptibility genes for vitamin D deficiency.
One of the limitations of our study was the relatively small sample size. Except for the haplotype analysis, no disease associations with polymorphisms reached a level of significance after correction for multiple testing. Another limitation was the lack of a comprehensive genetic analysis, which needs a far larger sample cohort. Moreover, we did not identify any clinical differences between patients with and without risk-associated haplotypes. This may have been because our group included only young children, and further analyses including patients of different ages may be necessary to clarify this point.
Recently, vitamin D supplementation has been rec- 
